Search
Protalix Biotherapeutics Inc
PLXAdd to Watchlist
2.215USD
+0.195+9.65%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
178.47MMarket Cap
11.47P/E TTM
Financial Health
Currency: USD Updated: 2026-06-17 The current financial score of Protalix Biotherapeutics Inc is 9.20, ranking 11 out of 157 in the Pharmaceuticals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 33.75M, representing a year-over-year increase of 233.73%, while its net profit experienced a year-over-year increase of 606.13%.
Financials
9.60
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.58
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.83
Free cash flow
Relevant data have not been disclosed by the company yet.
